Why the study?
Does insulin therapy alter myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus?
Does insulin therapy alter myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus?
Initiation of insulin therapy in type 2 diabetes is associated with an acute increase in myocardial lipid content and myocardial mass.
Should not yet change insulin initiation in T2DM; leaves open clinical relevance of acute myocardial lipid and mass changes.
The initiation of IT in patients with T2DM was followed by an acute rise in MYCL concentration and myocardial mass.
No takes yet. Share an insight, caveat, or question.
Janković et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: